Daniel Vitt is CEO at IMMUNIC, INC. (IMUX). They have made 6 open-market trades across 1 company since 2020, most recently 2025-06-04.
CIK 0001773673
5 open-market purchases totalling $66K since 2021, against 1 sale. Across 5 scored buys the stock is up 16.1% at ninety days, and 12.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMUX | 29,000 | $201K |
Shares reported on the most recent Form 4, priced at the 2025-06-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 80% |
| Avg Move | +0.0% | +6.6% | +16.1% |
| Alpha | +1.3% | +7.0% | +12.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMUX | BUY | 2025-06-04 | 2025-06-20 | $0.77 | $12K | -4.9% | +24.2% | +12.0% |
| IMUX | BUY | 2024-02-26 | 2024-02-28 | $1.31 | $18K | +1.4% | -3.5% | -11.3% |
| IMUX | BUY | 2022-11-22 | 2022-11-23 | $1.35 | $11K | -8.8% | -4.4% | +41.2% |
| IMUX | BUY | 2022-06-03 | 2022-06-06 | $3.10 | $16K | +8.1% | +16.1% | +31.0% |
| IMUX | BUY | 2021-08-10 | 2021-08-11 | $9.60 | $10K | +4.4% | +0.6% | +7.8% |
| IMUX | SELL | 2020-07-20 | 2020-07-22 | $14.68 | $93K | +32.5% | +11.0% | +6.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.